Hadar Ron

Hadar Ron, Founder and Managing Partner at Israel HealthCare Ventures (IHCV) is an active investor based in Irvine, California. This profile covers what Hadar Ron backs, at which stage, and how founders can reach out in 2026.

Dr. Hadar Ron is a Founding Partner and serves as Managing Partner at Israel Healthcare Ventures. She is a Managing Partner at Israel Healthcare Ventures (IHCV), a venture capital fund specializing in Life Science companies. She is the founding partner of Israel Healthcare Ventures Ltd. (IHCV), Israel's prime Life Science Venture Capital. She has extensive medical, legal, and management experience gained in senior positions in the financial, insurance, legal, and healthcare sectors. She serves as a member of the Advisory Board of the Momentum Fund tech transfer of Tel Aviv University. She serves as an active chairman of several companies, such as Supplant and GIVie, and as a board member of numerous medical companies. She is involved in many social and public initiatives in Israel, chairperson of Social Finance Israel, and chairperson of the scientific advisory board of Social Impact Bond for the prevention of diabetes and Colon Cancer. She also supports young scientists and new immigrants. She acts as a Board Member of Friends of the Sackler School of Medicine, Tel Aviv University, as well as a member of Women Business Leaders (WBL) International. Dr. Ron serves as a Board Member at InMode. He serves as a Board Member at Sanolla. He became a director of the Company in August 2019. She served as a Scientific Advisor at Integra Holdings. She also serves as Chairman at CureFacts. Since 2000, he has been the founding and managing partner of Israel Healthcare Ventures, an Israeli life science venture capital fund. He is also the chief executive officer of the management company for Israel Healthcare Ventures 2 LP Incorporated, or IHCV2, an Israeli life sciences venture capital fund. He served as a Board Member at CorAssist Cardiovascular and NanoPass Technologies. He serves as chairperson of G.I. View Ltd., a medical device company specializing in colorectal screenings, and CyTwist Ltd., an information technology start-up company, and as a board member of the following companies: Home Skinovations Ltd., SipNose Ltd., Pet Novations Ltd., Peri-Ness Technologies Ltd., Blender Ltd., O.G.D.H. Ltd., and OrSense Ltd. In addition, he serves as an external director of Together Pharma Ltd. In addition, he serves as a member of the advisory board of the Momentum Fund Tech Transfer of Tel Aviv University, a board member of BIRAD Ltd., the tech transfer company of Bar Ilan University, and is the chairperson of the scientific advisory board of Social Finance Israel's Social Impact Bond for the prevention of diabetes and colon cancer. He is a physician and attorney by education. She holds M.D. and L.L.B. degrees from Tel Aviv University and has studied at the School of Business Administration at Tel Aviv University.